Ainos, Inc. (AIMD)

NCM – Real Time Price. Currency in USD

1.73

-0.07 (-3.89%)

At close: Jun 26, 2026, 4:00 PM EDT

1.73

+0.00 (0.25%)

After-hours: Jun 26, 2026, 5:30 PM EDT

17.06.2026

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

Program expands Ainos' Smell AI platform from environmental intelligence into digital breath intelligence for emergency medicine research HOUSTON, TX / ACCESS Newswire / June 17, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization and Smell AI technologies, today announced a new research program with National Taiwan University ("NTU") to explore the use of Smell AI in emergency medicine. The program, titled "Rapid Diagnosis of Dyspneic Patients in the Emergency Department via AI-powered Electronic Nose Technology," will explore the use of Ainos' Smell AI platform to analyze volatile organic compounds ("VOCs") in exhaled breath.

08.06.2026

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

Building the Olfactory Layer of Physical AI Highlighting Progress Across Semiconductor Manufacturing, Healthcare Infrastructure and Physical AI Applications HOUSTON, TX / ACCESS Newswire / June 8, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization and Smell AI technologies, today released its 2026 Mid-Year Letter to Shareholders from Chairman, President and Chief Executive Officer Eddy Tsai. 2026 First Half Highlights Commercial Momentum Reported 499% year-over-year revenue growth during fiscal year 2025.

05.06.2026

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

HOUSTON, TX / ACCESS Newswire / June 5, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into machine-readable data for artificial intelligence applications, today highlighted a recent report published by VASRO GmbH ("VASRO"), discussing the expansion of the Company's AI Nose platform into emergency department operations and the continued growth of its Smell ID data across diverse real-world environments. In the report, VASRO reviews Ainos' recently announced research program at one of Asia's leading academic medical centers, where AI Nose is being deployed within a live emergency department environment to evaluate environmental scent analysis for emergency department overcrowding early warning and respiratory infection risk analysis.

03.06.2026

Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study

HOUSTON, TX / ACCESS Newswire / June 3, 2026 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into machine-readable data for artificial intelligence applications, today announced that Zacks Small-Cap Research ("Zacks SCR") has published a new article discussing Ainos' recently announced healthcare infrastructure study at National Taiwan University Hospital ("NTUH"). The article reviews Ainos' initiative to deploy AI Nose in a live emergency department environment and explores the potential role of Smell AI in environmental monitoring, healthcare infrastructure, and artificial intelligence applications.

01.06.2026

Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis

AI Nose Expands from Semiconductor Facilities into Frontline Healthcare Infrastructure HOUSTON, TX / ACCESS Newswire / June 1, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into machine-readable data for artificial intelligence applications, today announced the launch of a research program at National Taiwan University Hospital ("NTUH"), one of Asia's leading academic medical centers, to deploy AI Nose inside a live emergency department environment for intelligent environmental monitoring, ER overcrowding early warning, and respiratory infection risk analysis. The program aims to expand Smell AI, powered by AI Nose, inside a real-world emergency department environment and expands market opportunities beyond semiconductor and industrial environments into frontline healthcare infrastructure.

20.05.2026

VASRO Research Highlights Ainos AI Nose Commercialization Progress and Semiconductor Industry Shift Toward AI-Driven Environmental Intelligence

HOUSTON, TX / ACCESS Newswire / May 20, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today highlighted a new research update published by VASRO GmbH discussing AI Nose, the Company's AI-powered scent digitization and Smell AI platform, and ongoing commercialization progress across semiconductor manufacturing, robotics integration, and healthcare infrastructure markets. The report notes that the Company is advancing initiatives intended to support potential second half 2026 revenue generation.

13.05.2026

Ainos Reports First Quarter 2026 Financial Results and Highlights Smell AI Execution Across Semiconductors and Healthcare Infrastructure Markets

HOUSTON, TX / ACCESS Newswire / May 13, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced financial results for the first quarter ended March 31, 2026 and provided a business update on recent execution progress for AI Nose across semiconductors and healthcare infrastructure applications . During the first quarter of 2026, Ainos continued executing its commercialization priorities for AI Nose across industrial infrastructure environments while continuing to expand its Smell ID datasets and refine its Smell Language Model ("SLM") through deployment and pilot activities.

Videos

No Data

There is no data to display

Press releases

17.06.2026

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

08.06.2026

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

05.06.2026

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

03.06.2026

Ainos, Inc. (AIMD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ainos, Inc. (AIMD)

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study

Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis

VASRO Research Highlights Ainos AI Nose Commercialization Progress and Semiconductor Industry Shift Toward AI-Driven Environmental Intelligence

Ainos Reports First Quarter 2026 Financial Results and Highlights Smell AI Execution Across Semiconductors and Healthcare Infrastructure Markets

Videos

No Data

Press releases

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study

Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis

VASRO Research Highlights Ainos AI Nose Commercialization Progress and Semiconductor Industry Shift Toward AI-Driven Environmental Intelligence

Ainos Reports First Quarter 2026 Financial Results and Highlights Smell AI Execution Across Semiconductors and Healthcare Infrastructure Markets

Videos

No Data

Press releases

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study

Search stocks

Ainos, Inc. (AIMD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ainos, Inc. (AIMD)

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study

Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis

VASRO Research Highlights Ainos AI Nose Commercialization Progress and Semiconductor Industry Shift Toward AI-Driven Environmental Intelligence

Ainos Reports First Quarter 2026 Financial Results and Highlights Smell AI Execution Across Semiconductors and Healthcare Infrastructure Markets

Videos

No Data

Press releases

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study

Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis

VASRO Research Highlights Ainos AI Nose Commercialization Progress and Semiconductor Industry Shift Toward AI-Driven Environmental Intelligence

Ainos Reports First Quarter 2026 Financial Results and Highlights Smell AI Execution Across Semiconductors and Healthcare Infrastructure Markets

Videos

No Data

Press releases

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study